🔎 Trials Near Me

Utama › HPV › Texas

Kajian klinikal HPV di Texas

6 kajian untuk HPV sedang mencari peserta di lokasi di Texas.

Bandar di Texas

Teks kajian rasmi (Bahasa Inggeris)

Comparing Immune Response of 2 vs 3 HPV Doses (27-45 Years Old)

  • University of Texas Medical Branch, Galveston
Mengambil pesertaFasa 4Sukarelawan sihat dialu-alukanMenyebut bayaran untuk peserta
Umur 27 hingga 45 · Wanita · Dikemas kini 15 Sep 2026 · NCT05672927

A Study of a Selective T Cell Receptor (TCR) Targeting, Bifunctional Antibody-fusion Molecule STAR0602 in Participants With Advanced Solid Tumors

  • The University of Texas, MD Anderson Cancer Center, Houston
  • UT Health Mays Cancer Center, San Antonio
Mengambil pesertaFasa 1/2
Umur 18 ke atas · Semua jantina · Dikemas kini 11 Ogo 2026 · NCT05592626

Self-collection for HPV Testing to Improve Cervical Cancer Prevention (SHIP) Trial (LMI-001-A-S04)

  • UT MD Anderson Cancer Center, Houston
Mengambil pesertaSukarelawan sihat dialu-alukan
Umur 25 ke atas · Wanita · Dikemas kini 31 Jul 2026 · NCT07281430

Investigating Facilitator-driven, Multi-level Implementation Strategies in Federally Qualified Health Centers to Improve Provider Recommendation and HPV Vaccination Rates Among Latino/a Adolescents

  • The University of Texas Health Science Center at Houston, Houston
Mengambil peserta
Umur 11 hingga 17 · Semua jantina · Dikemas kini 4 Mei 2026 · NCT06598475

Artesunate Vaginal Inserts for the Treatment of Cervical Intraepithelial Neoplasia (CIN2/3)

  • The Harris Health System (L.B.J Hospital), Houston
  • University of Texas, M.D. Anderson, Houston
Mengambil pesertaFasa 2
Umur 25 hingga 100 · Wanita · Dikemas kini 2 Okt 2025 · NCT04098744

HPV Vaccine, Imiquimod, and Metformin Combination Trial

  • Baylor St. Luke's Medical Center- Dan L. Duncan Comprehensive Cancer Center, Houston
  • Harris Health Smith Clinic, Houston
Mengambil pesertaFasa 2
Umur 18 hingga 64 · Wanita · Dikemas kini 13 Nov 2024 · NCT06686043

Daripada ClinicalTrials.gov, data diperoleh pada 4 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.